Tag Archives: antitrust

AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required

AbbVie and Allergan have waited expectantly to seal the deal on their $ 63 billion merger as international watchdogs took a close look at the combo. Now, they’re almost home free. The EU says it’s prepared to give a green light to the deal—and a positive view from U.S. regulators could soon follow. The European Commission approved… Read More »